Skip to main content

Becton Dickinson Posts 8-Percent Rise in Fiscal Q4 Revenue as Profit Increases 17 Percent

NEW YORK (GenomeWeb News) — Becton Dickinson today said fiscal fourth-quarter revenues were up almost 8 percent and profits were up 17 percent.
 
BD said total receipts for the three months ended Sept. 30 increased to $1.5 billion from $1.4 billion year over year.  
 
R&D spending for the period increased to $83.6 million from $76.6 million.
 
The company said net income for the period increased to $174 million from $149 million last year.
 
Becton Dickinson did not report its balance sheet for the quarter.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.